SLC5A2 and diabetes mellitus: Despite its limitations, the present models are a stepping-stone to evaluate the renal mechanisms under the effect of commonly prescribed medications besides SGLT2 inhibitors, such as blockers of the angiotensin II system, in both women and men with diabetes, and to assess the impact of impaired kidney function.